CosMx SMI is Back Worldwide

Effective Immediately

Learn More

A New Era Begins!

Nanostring is now a Bruker company

Learn More

Proteomics Redefined

Discover the next IO drug target by spatially profiling 570+ proteins with the GeoMx® IO Proteome Atlas.

Learn More


With robust performance on even the most difficult samples and unparalleled flexibility… that’s Gene Expression You Can Count On!

Discover More
Silhouette of person jumping over gap

Make the Leap to Single-Cell Spatial

CosMx™ Human 6K Discovery Panel
Shipping Now

Unlock Unprecedented Biology with 6000 Genes

Request a Quote

Improving the
Human Condition

Catalyzing understanding

7,000 Publications and counting

Browse the vast and growing catalog of peer-reviewed research from oncology 
to biomarker discovery enabled by NanoString technologies.

View Publications


Become a Part of the Spatial Biology Revolution

“I have really enjoyed becoming a part of the company and teaching our customers more about the technologies NanoString offers and how to apply them to push their research forward.”

Amanda Mason

Field Applications Scientist

Amansa Mason smiling outdoors

“NanoString is a uniquely innovative place to work, as we get to do far more exciting and cutting-edge science than most companies our size. We experience the thrill of building technologies alongside the satisfaction that comes from participating in research advancing patient care for a broad range of disease areas.”

Erin Piazza

Senior Bioinformatics Scientist

Erin Piazza

“At NanoString Technologies I have a great opportunity to work with outstanding engineers and be part of the leading edge of gene expression instrumentation.”

Edgar Ali Lazcano Romano

Quality Control Engineer III

Amansa Mason smiling outdoors
Erin Piazza


CosMx™ Human Whole Transcriptome Panel
Blog Post Spatial Transcriptomics: Birth of GeoMx® Digital Spatial Profiler
Blog Post Gx Profiling Made Easy: The Birth of nCounter®
Blog Post Why Spatial Biology Enhances Spatial Transcriptomics Data
Blog Post Why is Spatial Transcriptomics Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D